The Abdala vaccine proved to be very effective and contributed to reducing the incidence of COVID-19 in Havana, in the midst of a very complex scenario of the entry of the Delta variant of SARS-CoV-2; one of the most contagious.
Along with compliance with the hygienic-sanitary measures directed by the country’s authorities, the vaccination with Abdala in Havana from July 11 to August 31, 2021, managed to reduce the incidence of the disease, in middle of the pandemic peak caused by the predominance of the Delta variant of the virus.
The Abdala vaccine protects 92% against the severe form of COVID-19 and 90.7% of death from this disease.
Of the people who became ill with COVID-19, those not vaccinated with Abdala in Havana were 11 times more prone to the severity of the disease than vaccinated people, demonstrating the high effectiveness of Abdala.
comments on